Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms

K Haslam, KM Molloy, E Conneally… - Clinical Chemistry and …, 2014 - degruyter.com
Myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic diseases
characterized by bone marrow proliferation of one or more of the myeloid cell lineages with …
被引用次数：10 相关文章

[引用][C] Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative …

K Haslam, KM Molloy, E Conneally… - Clinical chemistry …, 2014 - pubmed.ncbi.nlm.nih.gov
Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic
hematopoietic stem cell transplantation for myeloproliferative neoplasms Evaluation of a …

Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms

K Haslam, KM Molloy, E Conneally, SE Langabeer - degruyter.com
Myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic diseases
characterized by bone marrow proliferation of one or more of the myeloid cell lineages with …
[PDF] core.ac.uk

[PDF][PDF] Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative …

K Haslam, KM Molloy, E Conneally… - Mutation Status in …, 2019 - core.ac.uk
Myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic diseases
characterized by bone marrow proliferation of one or more of the myeloid cell lineages with …
[PDF] tudublin.ie

[PDF][PDF] Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative …

K Haslam, KM Molloy, E Conneally… - Mutation Status in …, 2019 - arrow.tudublin.ie
Myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic diseases
characterized by bone marrow proliferation of one or more of the myeloid cell lineages with …

[引用][C] Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative …

K Haslam, KM Molloy, E Conneally… - Clinical Chemistry and …, 2014 - europepmc.org
Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic
hematopoietic stem cell transplantation for myeloproliferative neoplasms. - Abstract - Europe …